The centralized facilities that allow for mass production and distribution are the primary emphasis of the traditional pharmaceutical manufacturing paradigm. Although this system consistently upholds high standards for both product quality and reproducibility, its rigidity places restrictions on emerging manufacturing technologies that could boost productivity and promote supply chain resilience. Agile manufacturing approaches, which make use of flexibility through portability and decentralization, enable manufacturers to immediately respond to patient needs and offer a potential solution to ensure timely access to life-saving medications. Agile methods are very useful when creating small-batch, individualized medicines that need to be tailored for each patient individually close to the point of service.
